Five | 合法醫療器材資訊網

In phase 1 of the ATOM2 study (treatment phase), 400 Asian children (aged 6e12 years) with myopia of А2.00 D or worse in each eye were randomized to receive ... Read More

由 A Chia 著作 · 2016 · 被引用 384 次 — In phase 1 of the ATOM2 study (treatment phase), 400 Asian children (aged 6–12 years) with myopia of −2.00 D or worse in each eye were ... Read More

由 A Chia 著作 · 2016 · 被引用 383 次 — In phase 1 of the ATOM2 study (treatment phase), 400 Asian children (aged 6–12 years) with myopia of −2.00 D or worse in each eye were ... Read More

由 A Chia 著作 · 2012 · 被引用 512 次 — Purpose: Our previous study, Atropine for the Treatment of Myopia 1 (ATOM1), showed that atropine 1% eyedrops were effective in controlling ... Read More

由 A Chia 著作 · 2016 · 被引用 384 次 — Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology. Read More

5 year Clinical Trial on Atropine for the treatment of Myopia. (ATOM2). Singapore National Eye Centre. Symposium 32: Hot Topics 2015, AAO 2015, Las Vegas. Read More

2021年8月16日 — Firstly, the ATOM2 study in 2012 investigated 0.5%, 0.1% and 0.01% atropine for efficacy, and found that in both refractive and axial length ... Read More

由 W Chua 著作 · 2003 · 被引用 13 次 — Abstract: : Purpose: The Atropine in the Treatment Of Myopia (ATOM) study is a randomized, double-masked, placebo-controlled trial designed to assess the ... Read More

由 V GALVIS 著作 · 2016 · 被引用 29 次 — The five-year results of the ATOM 2 study were published recently. After receiving atropine at different concentrations for 24 months (phase 1), individuals ... Read More

2020年2月10日 — Results from ATOM2 demonstrated that both atropine-related ocular adverse events and myopic rebound decreased with decreasing dose. The study ... Read More